We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Ginkgo Extract Protects Brain from Stroke Damage

By LabMedica International staff writers
Posted on 20 Oct 2008
An extract prepared from leaves of the Ginkgo biloba tree, long favored in Chinese and alternative medicine to improve brain function, has been found to protect the brain from some of the damage caused by ischemic stroke.

Investigators at Johns Hopkins University (Baltimore, MD, USA) induced stroke-like damage in a population of laboratory mice by briefly blocking an artery to one side of the brain. More...
Some of the animals in the study were treated with the Ginkgo extract, EGb761, prior to the stroke, while some of the animals received the treatment after the stroke. A control group was not treated with the extract.

Results published in the October 9, 2008, online edition of the journal Stroke revealed that the pretreated animals had 50.9% less neurological dysfunction and 48.2% smaller areas of brain damage than untreated mice. Treatment five minutes or four and a half hours after the stroke also led to significant reduction in damage.

The experiment was carried out a second time on a population of mice that had been genetically engineered to lack the gene for the enzyme heme oxygenase-1 (HO-1). HO-1 breaks down heme into carbon monoxide, iron, and biliverdin. It has been shown to act as an antioxidant and have a protective effect against inflammation in animal models. The HO-1 deficient animals did not show any benefit from EGb761 treatment, either before or after the stroke.

"Our results suggest that some element or elements in ginkgo actually protect brain cells during stroke,” explained senior author Dr. Sylvain Doré, associate professor of anesthesiology and critical care medicine at Johns Hopkins University. "Ginkgo increases HO-1 levels, and the antioxidant properties of this enzyme eliminate free radicals at the surrounding regions of the stroke site. Ginkgo has long been touted for its positive effects on the brain and is even prescribed in Europe and Asia for memory loss. Now we have a possible understanding for how Ginkgo actually works to protect neurons from damage.”

"It is still a large leap from rodent brains to human brains but these results strongly suggest that further research into the protective effects of Ginkgo is warranted,” said Dr. Doré. "If further work confirms what we have seen, we could theoretically recommend a daily regimen of ginkgo to people at high risk of stroke as a preventive measure against brain damage.”

Related Links:
Johns Hopkins University


Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Pipette Controller
Sapphire MaxiPette
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.